These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 14965146)

  • 1. Pharmacy benefit manager 'spread': a reasonable, rational, realistic business practice.
    Latanich T
    J Am Pharm Assoc (2003); 2004; 44(1):10-1. PubMed ID: 14965146
    [No Abstract]   [Full Text] [Related]  

  • 2. The spread: pilot study of an undocumented source of pharmacy benefit manager revenue.
    Garis RI; Clark BE
    J Am Pharm Assoc (2003); 2004; 44(1):15-21. PubMed ID: 14965148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Balancing medicine prices and business sustainability: analyses of pharmacy costs, revenues and profit shed light on retail medicine mark-ups in rural Kyrgyzstan.
    Waning B; Maddix J; Soucy L
    BMC Health Serv Res; 2010 Jul; 10():205. PubMed ID: 20626904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [More and more discount contracts. A chance to be free of the budget pressure].
    Schmidt K
    MMW Fortschr Med; 2007 May; 149(19):54-5. PubMed ID: 17668794
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacy benefit managers and their obligations during serious prescription drug shortages.
    Teagarden JR; Epstein RS
    Clin Pharmacol Ther; 2013 Feb; 93(2):143-5. PubMed ID: 23337523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Financing and Distribution of Pharmaceuticals in the United States.
    Dabora MC; Turaga N; Schulman KA
    JAMA; 2017 Jul; 318(1):21-22. PubMed ID: 28505252
    [No Abstract]   [Full Text] [Related]  

  • 7. Discriminatory pricing lawsuits could change future of community pharmacy.
    Flanagan ME
    Am Pharm; 1994 Oct; NS34(10):20-3. PubMed ID: 7992787
    [No Abstract]   [Full Text] [Related]  

  • 8. Creating reliable pharmaceutical distribution networks and supply chains in African countries: Implications for access to medicines.
    Tetteh E
    Res Social Adm Pharm; 2009 Sep; 5(3):286-97. PubMed ID: 19733829
    [No Abstract]   [Full Text] [Related]  

  • 9. State and federal government mandates are changing the face of pharmacy management.
    Giaquinta D
    Manag Care Interface; 2001 May; 14(5):50-2. PubMed ID: 11385948
    [No Abstract]   [Full Text] [Related]  

  • 10. [Price of medications: the actual system must be seen again].
    Mayencourt J
    Rev Med Suisse; 2016 Mar; 12(508):479. PubMed ID: 27089613
    [No Abstract]   [Full Text] [Related]  

  • 11. Provider boycotts--a review of the Merck-Medco decision. Merck-Medco Managed Care L.L.C. v. Rite Aid Corporation.
    Becker S
    Health Care Law Mon; 2000 May; ():10-8. PubMed ID: 14743588
    [No Abstract]   [Full Text] [Related]  

  • 12. [Medication prices in Germany--how are they determined?].
    Bruhn C
    Dtsch Med Wochenschr; 2010 Oct; 135(39):p34. PubMed ID: 20922657
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacies receiving massive rebates from generic drug-makers.
    Silversides A
    CMAJ; 2006 Aug; 175(4):342. PubMed ID: 16908889
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacies take uniform price demands to court.
    Moskowitz DB
    J Am Health Policy; 1994; 4(4):24-7. PubMed ID: 10136676
    [No Abstract]   [Full Text] [Related]  

  • 15. Contract price integrity for pharmaceuticals.
    Dunehew AR; Stokes H; Newberry J; Evangelista D
    Am J Health Syst Pharm; 2005 Feb; 62(4):422-9. PubMed ID: 15745898
    [No Abstract]   [Full Text] [Related]  

  • 16. Beyond the drugstore. Further expanding its scope, Walgreen inks deal with AmerisourceBergen.
    Sweeney B
    Mod Healthc; 2013 Mar; 43(12):17. PubMed ID: 23947257
    [No Abstract]   [Full Text] [Related]  

  • 17. How Pharmacy Benefit Managers Add to Financial Toxicity: The Copay Accumulator Program.
    Nabhan C; Phillips EG; Feinberg BA
    JAMA Oncol; 2018 Dec; 4(12):1665-1666. PubMed ID: 30286215
    [No Abstract]   [Full Text] [Related]  

  • 18. [Substitution of inhalation devices in the pharmacy according to a frame contract (dated 1st April, 2008) and individual discount regulations].
    Voshaar T
    Pneumologie; 2009 May; 63(5):288. PubMed ID: 19418388
    [No Abstract]   [Full Text] [Related]  

  • 19. [Substitution of inhalation devices in the pharmacy according to a frame contract (dated 1st April, 2008) and individual discount regulations].
    Hausen T
    Pneumologie; 2009 Feb; 63(2):78-9. PubMed ID: 19219767
    [No Abstract]   [Full Text] [Related]  

  • 20. [Parallel import of drugs for better and for worse].
    Krabbe U
    Ugeskr Laeger; 2004 Feb; 166(7):611. PubMed ID: 15005051
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.